SR

Sudhanshu Radhakrishna Kamat

Director Director DIN 00527705
DIN 00527705 First appointment Aug 2002 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Aug 2002
Shareholding value β€’β€’β€’β€’ Premium profile

About Sudhanshu Radhakrishna Kamat

Data last updated:

Sudhanshu Radhakrishna Kamat was a Director at Eli Lilly And Company (India ) Private Limited (2002–2014). The company operates in Pharma.

DIN 00527705
Primary Designation Director
Industry Pharma
First Appointment 22 Aug 2002

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director22 Aug 20021993₹1,004 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Eli Lilly And Company (India ) Private Limited
Premium access

Shareholding and investment profile for Sudhanshu Radhakrishna Kamat

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sudhanshu Radhakrishna Kamat

Sudhanshu Radhakrishna Kamat was first appointed on 22 Aug 2002 as Director at Eli Lilly And Company (India ) Private Limited.

Sudhanshu Radhakrishna Kamat held 1 earlier board appointment: Eli Lilly And Company (India ) Private Limited (Director, 22 Aug 2002 to 05 Sep 2014).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available